From the year-ago quarter ending June, Lockheed effectively generated the same revenue, at $18.12 billion vs $18.15 billion in Q2 2025. However, the company’s operating costs increased by $1.4 billion ...

Fiserv stock plunged over 16% despite beating Q2 earnings expectations, as the company lowered its full-year organic revenue ...

AT&T's second-quarter results have exceeded expectations, driven by robust growth in 5G and fiber subscribers.

Boston Scientific's Q2 2025 results exceeded expectations, with net sales of $5.061 billion and adjusted EPS of $0.75.

Thermo Fisher Scientific's second quarter of 2025 demonstrated a 3% revenue increase to $10.85 billion, slightly surpassing ...

Abivax shares surged over 400% in premarket trading after announcing positive Phase 3 results for its ulcerative colitis drug ...